Infant gastroesophageal reflux disease management consensus
Acta Paediatrica · 2024-03 · 113 (3) · 403-410
DOI: 10.1111/apa.17074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Acta Paediatrica, online erschienen am 20.12.2023. Verfasst von Yvan Vandenplas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Vrije Universiteit Brussel (VUB), UZ Brussel, KidZ Health Castle, Brussels, Belgium. Hauptthemen laut MEDLINE: Gastroesophageal Reflux. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Reckitt Benckiser Pharmaceuticals.
Abstract (Originalsprache)
Aim
Infant gastroesophageal reflux is mostly benign; however, when associated with complications like failure to thrive, it may be indicative of gastroesophageal reflux disease. There are currently several unmet needs pertaining to the management of infant gastroesophageal reflux (disease). Reflux in infants is mostly composed of breast milk or formula, so this population is significantly different to older children and adults. The objective of this Delphi consensus was to establish recommendations based on published literature and the experience of clinical experts in paediatric gastroenterology in the context of infant gastroesophageal reflux (disease).
Methods
The Delphi methodology was used to obtain a consensus on 18 statements relating to clinical aspects of infant gastroesophageal reflux (disease).
Results
The expert panel comprising paediatric gastroenterology clinical specialists reached a consensus for all statements by means of an online, anonymised voting system.
Conclusion
It was highlighted that there is generally low awareness of or adherence to guidelines in clinical practice and that acid suppression therapy should not be indicated for non‐acid reflux, which constitutes a significant proportion of total gastroesophageal reflux episodes among infants. Furthermore, it was emphasised that there is an unmet medical need for therapy for some symptomatic infants with non‐acid reflux disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Vrije Universiteit Brussel (VUB), UZ Brussel, KidZ Health Castle, Brussels, Belgium.
- Pediatric Gastroenterology, Hepatology & Transplant Unit, Hospital Italiano of Buenos Aires, Buenos Aires, Argentina.
- Department of Pediatric Gastroenterology and Nutrition, Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands.
- Department of Pediatrics, Manila Central University Hospital, Caloocan, Philippines.
- Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Centre for Paediatric Gastroenterology, Sheffield Children's Hospital, Weston Bank, Sheffield, UK.
ORCID-Profile: Yvan Vandenplas, Rachel Rosen
Förderung
- Reckitt Benckiser Pharmaceuticals
Zitieren
APA
Vandenplas, Y., Orsi, M., Benninga, M., Gatcheco, F., Rosen, R., & Thomson, M. (2024). Infant gastroesophageal reflux disease management consensus. Acta Paediatrica, 113(3), 403-410. https://doi.org/10.1111/apa.17074
Vancouver
Vandenplas Y, Orsi M, Benninga M, Gatcheco F, Rosen R, Thomson M. Infant gastroesophageal reflux disease management consensus. Acta Paediatrica. 2024;113(3):403-410. doi:10.1111/apa.17074
BibTeX
@article{Vandenplas2024,
author = {Vandenplas, Yvan and Orsi, Marina and Benninga, Marc and Gatcheco, Felizardo and Rosen, Rachel and Thomson, Mike},
title = {Infant gastroesophageal reflux disease management consensus},
journal = {Acta Paediatrica},
year = {2024},
volume = {113},
number = {3},
pages = {403--410},
doi = {10.1111/apa.17074}
}
EUVIMED